You're reading the free version. Trader adds the live tape and alerts.
Start tracking
AURX Buy Disclosure
Jorden David Emerson · SEC Form 4 · Filed Aug 31, 2026
Buy
Calculated transaction value
$844.23
Jorden David Emerson CEO/CFO
AURX
Transaction date
Aug 27, 2026
Public filing date
Aug 31, 2026
Filing lag
Filed 4 days later
AURX daily price context
No linked price history
This asset is not matched to a market-data symbol.
Source details
- Reported owner
- Not disclosed
- Source asset code
- Security
- Security
- Common Stock
- Quantity / price
- 789 shares @ $1.07
- SEC ownership
- Direct
- Transaction code
- P
- Form
- 4/A
- Filing identifier
- 0001437749-26-029257
Filing cohort
Transactions in this filing
Showing 2 of 2
Trades
2
Issuers
1
Estimated value
$9.54K
Buys / sales
2 / 0
| Issuer | Transaction | Traded | Value |
|---|---|---|---|
| Nuo Therapeutics, Inc. AURX | Buy | Aug 28, 2026 | $8.69K |
| Nuo Therapeutics, Inc. AURX Current | Buy | Aug 27, 2026 | $844.23 |